PortfoliosLab logo

Sino Biopharmaceutical Ltd (1177.HK)

Equity · Currency in HKD · Last updated May 27, 2023

Company Info

ISINKYG8167W1380
SectorHealthcare
IndustryBiotechnology

Highlights

Market CapHK$72.98B
EPSHK$0.10
PE Ratio27.71
PEG Ratio0.49
Revenue (TTM)HK$28.78B
Gross Profit (TTM)HK$21.53B
EBITDA (TTM)HK$6.75B
Year RangeHK$3.58 - HK$5.31
Target PriceHK$6.58

Share Price Chart


Loading data...

Performance

The chart shows the growth of an initial investment of HK$10,000 in Sino Biopharmaceutical Ltd, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


100.00%150.00%200.00%250.00%300.00%350.00%400.00%450.00%December2023FebruaryMarchAprilMay
293.27%
120.72%
1177.HK (Sino Biopharmaceutical Ltd)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with 1177.HK

Sino Biopharmaceutical Ltd

Return

Sino Biopharmaceutical Ltd had a return of -15.10% year-to-date (YTD) and -7.27% in the last 12 months. Over the past 10 years, Sino Biopharmaceutical Ltd had an annualized return of -2.74%, while the S&P 500 had an annualized return of 10.50%, indicating that Sino Biopharmaceutical Ltd did not perform as well as the benchmark.


PeriodReturnBenchmark
1 month-10.60%-0.59%
Year-To-Date-15.10%7.47%
6 months-8.49%2.91%
1 year-7.27%-4.20%
5 years (annualized)-27.29%8.77%
10 years (annualized)-2.74%10.50%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2023-0.44%-10.99%8.64%-1.36%
20223.25%20.21%-0.22%

Risk-Adjusted Performance

This table presents a comparison of risk-adjusted performance metrics for Sino Biopharmaceutical Ltd (1177.HK) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratioSortino ratioOmega ratioCalmar ratioUlcer Index
1177.HK
Sino Biopharmaceutical Ltd
-0.08
^GSPC
S&P 500
0.27

Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Sino Biopharmaceutical Ltd Sharpe ratio is -0.08. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-0.80-0.60-0.40-0.200.000.200.40December2023FebruaryMarchAprilMay
-0.08
0.07
1177.HK (Sino Biopharmaceutical Ltd)
Benchmark (^GSPC)

Dividend History

Sino Biopharmaceutical Ltd granted a 2.58% dividend yield in the last twelve months. The annual payout for that period amounted to HK$0.10 per share.


PeriodTTM20222021202020192018201720162015201420132012
DividendHK$0.10HK$0.10HK$0.04HK$0.05HK$0.04HK$0.04HK$0.02HK$0.02HK$0.01HK$0.02HK$0.01HK$0.01

Dividend yield

2.58%2.19%0.77%0.73%0.38%0.81%0.18%0.38%0.20%0.29%0.25%0.26%

Monthly Dividends

The table displays the monthly dividend distributions for Sino Biopharmaceutical Ltd. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDec
2023HK$0.00HK$0.00HK$0.00HK$0.00
2022HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.04HK$0.00HK$0.00HK$0.06HK$0.00HK$0.00HK$0.00
2021HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.02HK$0.00HK$0.00HK$0.02HK$0.00HK$0.00HK$0.00
2020HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.01HK$0.00HK$0.00HK$0.02HK$0.00HK$0.00HK$0.02
2019HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.01HK$0.00HK$0.00HK$0.01HK$0.00HK$0.00HK$0.01
2018HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.01HK$0.00HK$0.00HK$0.01HK$0.00HK$0.00HK$0.01
2017HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.01HK$0.00HK$0.01HK$0.00HK$0.01HK$0.00
2016HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.01HK$0.00HK$0.00HK$0.01HK$0.00HK$0.00HK$0.01
2015HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2014HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.01HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2013HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.01HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2012HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-80.00%-60.00%-40.00%-20.00%December2023FebruaryMarchAprilMay
-80.10%
-12.22%
1177.HK (Sino Biopharmaceutical Ltd)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the Sino Biopharmaceutical Ltd. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Sino Biopharmaceutical Ltd is 81.39%, recorded on Sep 28, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-81.39%May 29, 20181070Sep 28, 2022
-81.11%Apr 27, 20041064Oct 27, 2008382May 14, 20101446
-55.04%Nov 9, 2015155Jun 24, 2016341Nov 10, 2017496
-52.3%May 17, 2010475Apr 17, 2012165Dec 11, 2012640
-38.05%Oct 3, 20004Oct 9, 200093Feb 28, 200197

Volatility Chart

The current Sino Biopharmaceutical Ltd volatility is 7.42%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


5.00%10.00%15.00%20.00%December2023FebruaryMarchAprilMay
7.42%
4.15%
1177.HK (Sino Biopharmaceutical Ltd)
Benchmark (^GSPC)